Small Relief for Biogen in MS Drug Approval Small Relief for Biogen in MS Drug Approval

The U.S. Food and Drug Administration on Wednesday approved Biogen Inc ' s new oral drug to treat multiple sclerosis, offering the drugmaker some relief as its core franchise faces patent challenges.Reuters Health Information
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Neurology & Neurosurgery News Source Type: news